Related Experiment Video
Updated: Sep 27, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
[p73 gene expression in apoptotic process of acute myeloid leukemia cell line U937 induced by methotrexate]
Guang-Fen Xiao1, Qing Lu, Xiang-Dong Yang
1Department of Hematology, The Second Affiliated Hospital of Nanhua University, Hengyang 421001, China.
Abstract:
The purpose of this investigation was to study the variation of p73 gene expression in the apoptotic process of acute myeloid leukemia (AML) cell line U937 induced by methotrexate (MTX). Morphological changes of apoptotic cells were observed with microscopy and Wright's + Giemsa staining. DNA ladder and cell cycle were examined by agarose gel electrophoresis and flow cytometry respectively. Using semi-quantitive reverse transcription-polymerase chain reaction (RT-PCR), the expression of p73 mRNA was examined. Results showed that MTX could induce U937 cell apoptosis effectively. Condensed nuclei, fragmentation of chromosome and DNA ladder were seen after 6 hour following treatment of MTX 5 micro mol/L. Sub-G(1) peak and S + G(2)/M arrest were also determined by FCM, but the quantity of p73 expression was generally constant. In conclusion, U937 cell apoptosis induced by MTX did not change p73 mRNA level.
Insights
Methotrexate effectively induces apoptosis in acute myeloid leukemia U937 cells. However, this process does not alter the expression of the p73 gene mRNA in these cancer cells.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy.
- Understanding the molecular mechanisms of apoptosis in AML is crucial for developing targeted therapies.
- The p73 gene is a tumor suppressor and plays a role in apoptosis.
Purpose of the Study:
- To investigate the role of p73 gene expression during methotrexate-induced apoptosis in the U937 AML cell line.
- To analyze the impact of methotrexate on cell morphology, DNA integrity, and cell cycle progression in U937 cells.
Main Methods:
- U937 cells were treated with methotrexate (MTX).
- Apoptosis was assessed via microscopy, Wright's + Giemsa staining, and DNA laddering (agarose gel electrophoresis).
- Cell cycle analysis was performed using flow cytometry (FCM), and p73 mRNA expression was quantified using semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR).
Main Results:
- Methotrexate effectively induced apoptosis in U937 cells, evidenced by morphological changes like condensed nuclei and chromosome fragmentation.
- DNA laddering and a Sub-G1 peak in FCM indicated DNA damage and apoptosis.
- Cell cycle arrest was observed in the S and G2/M phases.
- Crucially, p73 mRNA expression levels remained constant throughout the apoptotic process.
Conclusions:
- Methotrexate is an effective inducer of apoptosis in the U937 AML cell line.
- The apoptotic process triggered by methotrexate in U937 cells does not involve alterations in p73 mRNA levels.
- These findings suggest that p73 gene expression is not a key regulator in MTX-induced apoptosis in this AML model.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
